HDAC6 inhibitors alleviate the symptoms of rheumatoid arthritis (RA) in rodents by downregulating the expression of pro-inflammatory mediators15,16, and alleviate symptoms and short-term memory loss in mouse MS models17. This evidence concerns the gene HDAC6 and rheumatoid arthritis.